Gagnon Securities LLC Pacira Bio Sciences, Inc. Transaction History
Gagnon Securities LLC
- $465 Million
- Q2 2025
A detailed history of Gagnon Securities LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Gagnon Securities LLC holds 368,353 shares of PCRX stock, worth $8.04 Million. This represents 1.89% of its overall portfolio holdings.
Number of Shares
368,353
Previous 308,334
19.47%
Holding current value
$8.04 Million
Previous $7.66 Million
14.89%
% of portfolio
1.89%
Previous 1.82%
Shares
25 transactions
Others Institutions Holding PCRX
# of Institutions
256Shares Held
50.9MCall Options Held
157KPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$175 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$114 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$49.4 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$48.9 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$44.7 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...